Continue to site >
Trending ETFs

Transamerica Mid Cap Value Opportunities

mutual fund
MCVAX
Payout Change
Pending
Price as of:
$12.03 -0.01 -0.08%
primary theme
U.S. Mid-Cap Value Equity
MCVAX (Mutual Fund)

Transamerica Mid Cap Value Opportunities

Payout Change
Pending
Price as of:
$12.03 -0.01 -0.08%
primary theme
U.S. Mid-Cap Value Equity
MCVAX (Mutual Fund)

Transamerica Mid Cap Value Opportunities

Payout Change
Pending
Price as of:
$12.03 -0.01 -0.08%
primary theme
U.S. Mid-Cap Value Equity

Name

As of 12/11/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$12.03

$1.39 B

0.52%

$0.06

1.20%

Vitals

YTD Return

9.9%

1 yr return

16.3%

3 Yr Avg Return

3.3%

5 Yr Avg Return

7.3%

Net Assets

$1.39 B

Holdings in Top 10

26.6%

52 WEEK LOW AND HIGH

$12.0
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.20%

SALES FEES

Front Load 5.50%

Deferred Load N/A

TRADING FEES

Turnover 54.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000

IRA

$1,000


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 12/11/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$12.03

$1.39 B

0.52%

$0.06

1.20%

MCVAX - Profile

Distributions

  • YTD Total Return 9.9%
  • 3 Yr Annualized Total Return 3.3%
  • 5 Yr Annualized Total Return 7.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.06%
DIVIDENDS
  • Dividend Yield 0.5%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Transamerica Mid Cap Value Opportunities
  • Fund Family Name
    Transamerica
  • Inception Date
    Mar 24, 2017
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Brett Hawkins

Fund Description

Under normal circumstances, the fund invests at least 80% of its net assets (plus the amount of borrowings, if any, for investment purposes) in equity securities of mid cap companies. The fund's sub-adviser, Thompson, Siegel & Walmsley LLC (the “sub-adviser”), considers mid cap companies to be those companies, at the time of purchase, with market capitalizations within the range of companies included in the Russell Midcap® Value Index1 (between approximately $6 billion and $47 billion as of June 30, 2023, the date of the last reconstitution). The size of the companies in the Russell Midcap® Value Index will change with market conditions. The fund invests primarily in common stocks. The fund may invest in other equity and non-equity securities, including preferred stocks, convertible securities and foreign securities which may take the form of depositary receipts.The sub-adviser seeks to invest in companies it believes present a value or potential worth that is not recognized by prevailing market prices or that have experienced some fundamental changes and are intrinsically undervalued by the investment community. The sub-adviser's mid cap value process uses a combination of quantitative and qualitative methods and is based on a four-factor valuation screen. Parts one and two of the screen attempt to assess a company's discount to private market value relative to other mid cap stocks. The third factor considers the relative earnings prospects of the company. The fourth factor involves looking at the company's recent price action. Value stocks as a group may be out of favor and underperform the overall equity market for a long period of time, for example, while the market favors “growth” stocks.The sub-adviser's analysts also explore numerous factors that might affect the outlook for a company. They evaluate publicly available information including, but not limited to, sell-side research, company filings, and trade periodicals. The analysts may speak with company management to hear their perspectives and outlook on pertinent business issues. They apply a consistent and disciplined review in a team environment that encourages critical thinking and analysis for each company considered for investment.The sub-adviser generally considers selling a security when the catalyst for the investment is no longer valid, when the sub-adviser believes that another stock will have a higher expected return, or for portfolio risk management. The fund generally engages in active and frequent trading of portfolio securities as part of its principal investment strategy.1 “Russell®” and other service marks and trademarks related to the Russell indexes are trademarks of the London Stock Exchange Group companies.
Read More

MCVAX - Performance

Return Ranking - Trailing

Period MCVAX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.9% 4.1% 35.1% 92.50%
1 Yr 16.3% 8.6% 42.4% 91.94%
3 Yr 3.3%* -0.9% 16.9% 94.93%
5 Yr 7.3%* 0.8% 18.2% 92.53%
10 Yr 7.7%* 1.9% 12.1% 76.43%

* Annualized

Return Ranking - Calendar

Period MCVAX Return Category Return Low Category Return High Rank in Category (%)
2023 6.1% -11.3% 33.3% 69.17%
2022 -12.8% -41.6% 2.3% 42.70%
2021 -2.6% -41.5% 44.9% 95.77%
2020 3.2% -29.0% 22.1% 29.80%
2019 20.2% -8.1% 31.2% 61.83%

Total Return Ranking - Trailing

Period MCVAX Return Category Return Low Category Return High Rank in Category (%)
YTD 9.9% 4.1% 35.1% 92.50%
1 Yr 16.3% 8.6% 42.4% 91.94%
3 Yr 3.3%* -0.9% 16.9% 94.93%
5 Yr 7.3%* 0.8% 18.2% 92.53%
10 Yr 7.7%* 1.9% 12.1% 76.43%

* Annualized

Total Return Ranking - Calendar

Period MCVAX Return Category Return Low Category Return High Rank in Category (%)
2023 11.0% -1.7% 36.5% 67.50%
2022 -12.1% -35.0% 2.4% 85.96%
2021 25.3% 6.2% 48.3% 78.31%
2020 3.8% -22.9% 23.2% 41.26%
2019 24.1% -3.0% 35.7% 73.08%

NAV & Total Return History


MCVAX - Holdings

Concentration Analysis

MCVAX Category Low Category High MCVAX % Rank
Net Assets 1.39 B 991 K 28 B 35.73%
Number of Holdings 71 8 2308 62.60%
Net Assets in Top 10 343 M 349 K 5.52 B 36.01%
Weighting of Top 10 26.59% 4.6% 100.2% 30.19%

Top 10 Holdings

  1. FIXED INC CLEARING CORP.REPO 5.18%
  2. Dominion Energy, Inc. 3.06%
  3. Huntington Ingalls Industries, Inc. 2.71%
  4. Evergy, Inc. 2.51%
  5. NiSource, Inc. 2.42%
  6. OGE Energy Corp. 2.28%
  7. Bio-Rad Laboratories, Inc. 2.25%
  8. Walgreens Boots Alliance, Inc. 2.06%
  9. Centene Corp. 2.06%
  10. Labcorp Holdings, Inc. 2.05%

Asset Allocation

Weighting Return Low Return High MCVAX % Rank
Stocks
94.83% 55.64% 103.53% 91.14%
Other
5.18% 0.00% 7.98% 1.11%
Preferred Stocks
0.00% 0.00% 1.68% 35.46%
Convertible Bonds
0.00% 0.00% 0.02% 29.81%
Cash
0.00% 0.00% 27.43% 92.80%
Bonds
0.00% 0.00% 19.09% 33.24%

Stock Sector Breakdown

Weighting Return Low Return High MCVAX % Rank
Financial Services
17.11% 0.00% 60.11% 59.33%
Communication Services
14.20% 0.00% 19.80% 1.67%
Healthcare
11.40% 0.00% 32.47% 26.74%
Utilities
11.22% 0.00% 24.69% 4.46%
Energy
10.04% 0.00% 29.17% 18.38%
Technology
9.85% 0.00% 30.07% 47.91%
Consumer Cyclical
6.43% 0.00% 29.62% 88.58%
Industrials
6.02% 0.00% 29.02% 94.99%
Consumer Defense
5.97% 0.00% 33.79% 42.90%
Real Estate
4.72% 0.00% 40.74% 76.60%
Basic Materials
3.04% 0.00% 23.88% 77.72%

Stock Geographic Breakdown

Weighting Return Low Return High MCVAX % Rank
US
94.83% 55.64% 103.53% 76.73%
Non US
0.00% 0.00% 33.85% 44.04%

MCVAX - Expenses

Operational Fees

MCVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.20% 0.06% 16.92% 33.33%
Management Fee 0.70% 0.00% 1.20% 46.26%
12b-1 Fee 0.25% 0.00% 1.00% 39.68%
Administrative Fee N/A 0.01% 0.40% 4.98%

Sales Fees

MCVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.50% 3.50% 5.75% 56.82%
Deferred Load N/A 1.00% 4.00% N/A

Trading Fees

MCVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

MCVAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 54.00% 0.00% 227.00% 56.23%

MCVAX - Distributions

Dividend Yield Analysis

MCVAX Category Low Category High MCVAX % Rank
Dividend Yield 0.52% 0.00% 22.79% 27.22%

Dividend Distribution Analysis

MCVAX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Quarterly Annual

Net Income Ratio Analysis

MCVAX Category Low Category High MCVAX % Rank
Net Income Ratio 0.06% -1.84% 4.73% 90.22%

Capital Gain Distribution Analysis

MCVAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

MCVAX - Fund Manager Analysis

Managers

Brett Hawkins


Start Date

Tenure

Tenure Rank

Apr 30, 2014

8.09

8.1%

Joined TSW in 2001 University of Richmond, BA, 1993; University of Virginia, Darden School, MBA, 1999 Arthur Andersen LLP - Senior Associate First Union Corporation - Assistant Vice President, Equity Research

R. Michael Creager


Start Date

Tenure

Tenure Rank

Mar 01, 2019

3.25

3.3%

Western Kentucky University, BS, 1993; Hofstra University, MBA, 1995 Providian Capital Management Corp.- AVP, Financial Analyst A.G. Edwards & Sons, Inc. - AVP, Associate Equity Analyst Wachovia Securities, LLC - AVP, Associate Equity Analyst BB&T Capital Markets - Vice President, Equity Analyst

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 35.59 8.15 10.92